{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T04:47:34Z","timestamp":1750481254623},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1991,1,1]],"date-time":"1991-01-01T00:00:00Z","timestamp":662688000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother. Pharmacol."],"published-print":{"date-parts":[[1991]]},"DOI":"10.1007\/bf00688864","type":"journal-article","created":{"date-parts":[[2004,11,28]],"date-time":"2004-11-28T16:57:07Z","timestamp":1101661027000},"page":"394-396","source":"Crossref","is-referenced-by-count":23,"title":["High-dose epirubicin as primary chemotherapy in advanced breast carcinoma: a phase II study"],"prefix":"10.1007","volume":"27","author":[{"given":"J.","family":"Carmo-Pereira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. O.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. W.","family":"Miles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Henriques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Richards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. D.","family":"Rubens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/bjc.1989.234","volume":"60","author":"MH Bronchud","year":"1989","unstructured":"Bronchud MH, Howell A, Crowther D, Hopwood P, Souza L, Dexter TM (1989) The use of granulocyte colony-stimulting factor to increaase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer. Br J Cancer 60: 121?125","journal-title":"Br J Cancer"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/bjc.1987.226","volume":"56","author":"J Carmo-Pereira","year":"1987","unstructured":"Carmo-Pereira J, Costa FO, Henriques E, Godinho R, Cantinho-Lopes G, Sales-Luis A, Rubens RD (1987) A comparison of two doses of Adriamycon in the primary chemotherapy of disseminated breast carcinoma. Br J Cancer 56: 471?473","journal-title":"Br J Cancer"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/bjc.1977.42","volume":"35","author":"JL Hayward","year":"1977","unstructured":"Hayward JL, Rubens RD, Carbone PP, Heuson J-C, Kumaoka S, Segaloff A (1977) Assessment of response to therapy in advanced breast cancer. Br J Cancer 35: 292?298","journal-title":"Br J Cancer"},{"key":"CR4","first-page":"34","volume":"14","author":"C Henderson","year":"1987","unstructured":"Henderson C, Hayes D, Come S, Harris J, Canellos G (1987) New agents and new medical treatments for advanced breast cancer. Semin Oncol 14: 34?64","journal-title":"Semin Oncol"},{"key":"CR5","first-page":"65","volume":"14","author":"WM Hryniuk","year":"1987","unstructured":"Hryniuk WM (1987) Average relative dose intensity and the impact on design of clinical trials. Semin Oncol 14: 65?74","journal-title":"Semin Oncol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/0277-5379(83)90085-8","volume":"19","author":"R Steiner","year":"1983","unstructured":"Steiner R, Stewart J, Cantwell B, Minton M, Knight R, Rubens RD (1983) Adriamycin alone or combined with vincristine in the treatment of advanced breast cancer. Eur J Cancer Clin Oncol 19: 1553?1557","journal-title":"Eur J Cancer Clin Oncol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/1097-0142(19820301)49:5<835::AID-CNCR2820490502>3.0.CO;2-Z","volume":"49","author":"B Tranum","year":"1982","unstructured":"Tranum B, McDonald B, Thigpen T, Vaughan C, Wilson H, Maloney, Costanzi J, Bickers J, Gad el Mawli N, Palmer R, Hoogstraten E, Heilburn L, Rasmusen S (1982) Adriamycin combinations in advanced breast cancer. Cancer 49: 835?839","journal-title":"Cancer"},{"key":"CR8","unstructured":"Van Oosterom AT, Anderson M, Wildiers J, Klijn J, Jassem J, Peridaens R, Rotmensz N, Sylvester R, Mouridsen H (1987) Adriamycin versus 4-Epi-adriamycin, report of a second-line randomised phase III study in advanced breast cancer (Trial 10 811) (abstract 436). Proceedings, 4th EORTC Breast Cancer Working Conference"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00688864.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00688864\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00688864","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T18:40:41Z","timestamp":1554835241000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00688864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1991]]}},"alternative-id":["BF00688864"],"URL":"https:\/\/doi.org\/10.1007\/bf00688864","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991]]}}}